Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook.

Dunn WB, Goodacre R, Neyses L, Mamas M.

Bioanalysis. 2011 Oct;3(19):2205-22. doi: 10.4155/bio.11.223. Review.

PMID:
21985415
2.

Metabolomic approach to foetal and neonatal heart.

Bassareo PP, Fanos V, Deidda M, Barberini L, Mercuro G.

J Matern Fetal Neonatal Med. 2012 Oct;25(Suppl 5):19-21. doi: 10.3109/14767058.2012.714632. Review.

PMID:
23025764
3.

The role of metabolites and metabolomics in clinically applicable biomarkers of disease.

Mamas M, Dunn WB, Neyses L, Goodacre R.

Arch Toxicol. 2011 Jan;85(1):5-17. doi: 10.1007/s00204-010-0609-6. Epub 2010 Oct 16. Review.

PMID:
20953584
4.

Emerging applications of metabolomics in drug discovery and precision medicine.

Wishart DS.

Nat Rev Drug Discov. 2016 Jul;15(7):473-84. doi: 10.1038/nrd.2016.32. Epub 2016 Mar 11. Review.

PMID:
26965202
5.

Recent and potential developments of biofluid analyses in metabolomics.

Zhang A, Sun H, Wang P, Han Y, Wang X.

J Proteomics. 2012 Feb 2;75(4):1079-88. doi: 10.1016/j.jprot.2011.10.027. Epub 2011 Nov 4. Review.

PMID:
22079244
6.

Metabolomics for laboratory diagnostics.

Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R.

J Pharm Biomed Anal. 2015 Sep 10;113:108-20. doi: 10.1016/j.jpba.2014.12.017. Epub 2014 Dec 25. Review.

PMID:
25577715
7.

Application of metabolomics to diagnosis of insulin resistance.

Milburn MV, Lawton KA.

Annu Rev Med. 2013;64:291-305. doi: 10.1146/annurev-med-061511-134747. Review.

PMID:
23327524
8.

Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.

McKillop AM, Flatt PR.

Diabetes Care. 2011 Dec;34(12):2624-30. doi: 10.2337/dc11-0837. Review.

9.

A practical guide to metabolomic profiling as a discovery tool for human heart disease.

Heather LC, Wang X, West JA, Griffin JL.

J Mol Cell Cardiol. 2013 Feb;55:2-11. doi: 10.1016/j.yjmcc.2012.12.001. Epub 2012 Dec 8. Review.

PMID:
23231771
10.

Metabolomics in human type 2 diabetes research.

Lu J, Xie G, Jia W, Jia W.

Front Med. 2013 Mar;7(1):4-13. doi: 10.1007/s11684-013-0248-4. Epub 2013 Feb 2. Review.

PMID:
23377891
11.

The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development.

Puri R, Nissen SE.

Curr Pharm Des. 2013;19(33):5963-71. Review.

PMID:
23438963
12.

Current Trends and Innovations in Bioanalytical Techniques of Metabolomics.

Zhang T, Zhang A, Qiu S, Yang S, Wang X.

Crit Rev Anal Chem. 2016 Jul 3;46(4):342-51. doi: 10.1080/10408347.2015.1079475. Epub 2015 Sep 4. Review.

PMID:
26337255
13.

Metabolomics in diabetes research.

Friedrich N.

J Endocrinol. 2012 Oct;215(1):29-42. doi: 10.1530/JOE-12-0120. Epub 2012 Jun 20. Review.

14.

Metabolomics: moving to the clinic.

Nordström A, Lewensohn R.

J Neuroimmune Pharmacol. 2010 Mar;5(1):4-17. doi: 10.1007/s11481-009-9156-4. Epub 2009 Apr 28. Review.

PMID:
19399626
15.

The emergence of metabolomics as a key discipline in the drug discovery process.

Fillet M, Frédérich M.

Drug Discov Today Technol. 2015 Jun;13:19-24. doi: 10.1016/j.ddtec.2015.01.006. Epub 2015 Feb 28. Review.

PMID:
26190679
16.

Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.

Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE.

Mol Biosyst. 2010 May;6(5):909-21. doi: 10.1039/b914182k. Epub 2010 Mar 23.

PMID:
20567778
17.

Capillary electrophoresis-mass spectrometry in metabolomics: the potential for driving drug discovery and development.

Wang X, Li K, Adams E, Van Schepdael A.

Curr Drug Metab. 2013 Sep;14(7):807-13. Review.

PMID:
23937174
18.

The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses.

Serkova NJ, Standiford TJ, Stringer KA.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):647-55. doi: 10.1164/rccm.201103-0474CI. Epub 2011 Jun 16. Review.

19.

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.

Beger RD, Sun J, Schnackenberg LK.

Toxicol Appl Pharmacol. 2010 Mar 1;243(2):154-66. doi: 10.1016/j.taap.2009.11.019. Epub 2009 Nov 22. Review.

PMID:
19932708
20.

Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease.

Barallobre-Barreiro J, Chung YL, Mayr M.

Rev Esp Cardiol (Engl Ed). 2013 Aug;66(8):657-61. doi: 10.1016/j.rec.2013.04.009. Epub 2013 Jul 2. Review.

PMID:
24776335

Supplemental Content

Support Center